This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke, Volume 55, Issue Suppl_1 , Page AWP100-AWP100, February 1, 2024. Introduction:IV thrombolysis is a proven treatment for acute ischemic stroke (AIS), but it is still underutilized in real-world clinical practice. Urgent interventions to increase IV thrombolysis rates are needed to improve acute stroke care.
Stroke, Volume 56, Issue Suppl_1 , Page AWP13-AWP13, February 1, 2025. Introduction:Strokes affecting the posterior circulation (PCS) account for 20% of all ischemic strokes. The number of stroke mimics presenting with isolated dizziness who received thrombolysis was 11 in 2021, 16 in 2022, 9 in 2023, and 11 in 2024.
Stroke, Volume 55, Issue Suppl_1 , Page AWP16-AWP16, February 1, 2024. Introduction:Trials using advanced imaging have shown a benefit from intravenous thrombolysis in patients with wake-up stroke, but real-world data is limited. in those able to receive perfusion imaging). Median admission NIHSS was 6. days (mean LOS 3.6
Stroke, Volume 55, Issue Suppl_1 , Page ATP117-ATP117, February 1, 2024. Introduction:Reducing door-to-needle (DTN) times lead to improved patient outcomes in acute ischemic stroke. 2) Creation of a multidisciplinary Thrombolysis Focus Group to analyze data and improve processes. in 2022, to 88.6% in 2022, to 88.6%
Stroke, Volume 56, Issue Suppl_1 , Page ATMP26-ATMP26, February 1, 2025. Introduction:Telestroke has the potential to revolutionize acute stroke treatment by improving access to optimal stroke care, including time-sensitive care such as thrombolysis. Telestroke patients were more commonly at primary stroke centers (71.1%
Stroke, Volume 56, Issue Suppl_1 , Page AWP72-AWP72, February 1, 2025. Background:Our system, comprised of 21 Northeast Ohio hospitals includes 3 Stroke Ready, 10 Primary and 1 Comprehensive Stroke Center (CSC). Alteplase was the standardized thrombolytic until 2022. EHR Alteplase references were changed to thrombolysis.
Stroke, Ahead of Print. Cervical artery dissection is an important cause of stroke, particularly in young adults. In patients with acute ischemic stroke attributable to cervical artery dissection, acute treatment strategies such as thrombolysis and mechanical thrombectomy are reasonable in otherwise eligible patients.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP23-ATMP23, February 1, 2024. Background:Studies have reported longer emergency department (ED) wait times and delayed stroke treatment for Black versus White patients. Minority patients also have severe stroke symptoms compared to White patients.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionImportance:Tenecteplase (TNK) use is more prevalent as the thrombolytic drug of choice for acute ischemic stroke (AIS), given its ease of use with results from randomized trials showing non‐ inferiority and comparable safety to Alteplase (tPA).
Stroke, Volume 56, Issue Suppl_1 , Page ATMP44-ATMP44, February 1, 2025. Introduction:Understanding factors that contribute to missed diagnoses of acute ischemic stroke (AIS) may improve diagnostic accuracy. treatment window for thrombolysis. treatment window for thrombolysis. window (60% vs 40%, p<0.01).
Stroke, Volume 55, Issue Suppl_1 , Page A144-A144, February 1, 2024. Introduction:CTP has increasingly been incorporated into the evaluation of all patients with suspected acute ischemic stroke (AIS), including those with minor symptoms. years (IQR 54-73) and 56% were women. 73% were Black or African American, 20% White, and 4% Asian.
Stroke, Volume 55, Issue Suppl_1 , Page ATP104-ATP104, February 1, 2024. Introduction:Accurate outcome prognostication in acute ischemic stroke (AIS) informs essential medical decision-making for clinicians, patients, and families. Cases with a modified Rankin scale (mRS) of 0-2 at 90 days (i.e.
Stroke, Volume 55, Issue Suppl_1 , Page ATP66-ATP66, February 1, 2024. Introduction:Alteplase was the first approved tissue plasminogen activator and standard of care for acute ischemic stroke (AIS). Patients prior to November 2022 received Alteplase, and those after November 2022 received Tenecteplase. Alteplase vs 53.09
Stroke, Volume 55, Issue Suppl_1 , Page ATP108-ATP108, February 1, 2024. Introduction:The Alberta Stroke Program Early CT Score (ASPECTS) is often used in considering whether patients are appropriate for thrombolysis and/or thrombectomy after acute ischemic stroke (AIS).
Stroke, Volume 56, Issue Suppl_1 , Page AWMP53-AWMP53, February 1, 2025. Background:Treatment options and outcomes in stroke also depends on pre-hospital delays. Compared to the patients who reached by non-EMS mode, patients who reached by EMS mode were more likely to receive intravenous thrombolysis (16% vs 44%,).
Stroke, Volume 55, Issue Suppl_1 , Page A34-A34, February 1, 2024. A change in the stroke alert process (January 2023) focused on early notification of stroke alert, CT and telestroke. After changing the ED stroke process, there was a reduction in DTN of 29.26
Stroke, Volume 56, Issue Suppl_1 , Page AWP165-AWP165, February 1, 2025. This is especially critical for wake-up strokes where emergent brain magnetic resonance imaging (eMRI-brain) is included in the evaluation process. It is important to note that stroke onset may have influenced the presence of DWI-FLAIR mismatch.
Stroke, Volume 56, Issue Suppl_1 , Page ADP43-ADP43, February 1, 2025. Objective:Most patients with concern for an acute stroke are transported by Emergency Medical Services (EMS) or a Mobile Stroke Unit (MSU) from community hospitals to a Comprehensive Stroke Center (CSC).
Stroke, Volume 55, Issue Suppl_1 , Page A78-A78, February 1, 2024. 1–3Mobile Stroke Units (MSUs) bring diagnostic and treatment tools for AIS directly to patients, achieving faster thrombolytic administration and better outcomes.4,5Objective:This Per capita income did not differ.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP86-ATMP86, February 1, 2024. Introduction:Tenecteplase improves reperfusion and functional outcomes in stroke patients with large vessel occlusion. Use of TPA was converted to TNK on 1/11/2022 per hospital policy. Secondary outcomes were NIHSS at 24 hours and at discharge. versus 7.0,
Stroke, Volume 56, Issue Suppl_1 , Page ATP172-ATP172, February 1, 2025. hours of last known well time follow the code stroke algorithm predicated on BEFAST symptoms. If photo is consistent with an RAO, thrombolysis is offered.Results:From July 2022 to June 2024, 1079 fundus photos were obtained across 10 stroke centers.
Stroke, Volume 55, Issue Suppl_1 , Page ATP43-ATP43, February 1, 2024. Background:Stroke centers following AHA guidelines for the treatment of acute ischemic stroke, are challenged by compliance with documentation of vital sign, neuro and neurovascular assessments post thrombolysis interventions.
Stroke, Volume 55, Issue Suppl_1 , Page AWMP78-AWMP78, February 1, 2024. Introduction:Mobile stroke units (MSUs) are an evolving means to expedited acute stroke management.
Stroke, Volume 55, Issue Suppl_1 , Page A24-A24, February 1, 2024. Introduction:Tenecteplase (TNK) has arisen as an alternative to alteplase (ALT) for emergent treatment of acute ischemic stroke. The exposure was treatment with TNK vs ALT. The primary endpoints were DTN and DIDO.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionThe mantra ‘time is brain’ cannot be overstated for patients suffering from acute ischemic stroke. DIDO was defined as the time between spoke hospital door in arrival and door out exit.
Stroke, Volume 55, Issue Suppl_1 , Page AWP126-AWP126, February 1, 2024. Methods:Data for this study were obtained from the Get with the Guidelines Stroke database. Methods:Data for this study were obtained from the Get with the Guidelines Stroke database.
Stroke, Volume 55, Issue Suppl_1 , Page AWP10-AWP10, February 1, 2024. Introduction:While observational data suggest that dexmedetomidine may have neuroprotective effects on ischemic brain, its clinical use in acute ischemic stroke is limited due to concerns about cerebral vasoconstriction. vs. 28.8%; p=0.24).
Stroke: Vascular and Interventional Neurology, Ahead of Print. BACKGROUNDIn patients with acute ischemic stroke secondary to large vessel occlusion, achieving modified Thrombolysis in Cerebral Infarction (mTICI) 2c/3 (excellent recanalization) over mTICI 2b is associated with improved functional outcomes.
Stroke, Volume 55, Issue Suppl_1 , Page AWP192-AWP192, February 1, 2024. Introduction:Despite comparable outcomes for different frontline techniques in mechanical thrombectomy (MT) for acute ischemic stroke (AIS), there are sparse data regarding if and when to switch techniques if the first pass is unsuccessful.
Stroke, Volume 55, Issue Suppl_1 , Page AWP191-AWP191, February 1, 2024. Introduction:The mantra ‘time is brain’ cannot be overstated for patients suffering from acute ischemic stroke. The median NIHSS was 16 (10-20), 50% were treated with intravenous thrombolysis at a spoke, and TICI 2B-3 reperfusion was achieved in 87% at the hub.
Stroke, Volume 55, Issue Suppl_1 , Page AWP205-AWP205, February 1, 2024. The aim of this study is to develop and validate a stroke prediction tool for outcome in MT for AIS patients with low ASPECTS using data from an ongoing international multicenter registry, the Stroke Thrombectomy and Aneurysm Registry (STAR).Methods:236
Stroke, Volume 55, Issue Suppl_1 , Page ATP193-ATP193, February 1, 2024. Successful recanalization was defined as modified Thrombolysis in Cerebral Ischemia Score≥ 2b. The primary outcome was a 90-day modified Rankin Scale (mRS) of 0-3.
Stroke: Vascular and Interventional Neurology, Ahead of Print. BACKGROUNDAs the number of thrombectomy passes increases during endovascular therapy (EVT) for acute stroke, neurointerventionalists must weigh the risks of potential complications against the risk of failing to recanalize the affected vessel.
Stroke: Vascular and Interventional Neurology, Ahead of Print. male, median age 75 (interquartile range 65–82) years, and median National Institutes of Health Stroke Scale score 8 (5–12). male, median age 75 (interquartile range 65–82) years, and median National Institutes of Health Stroke Scale score 8 (5–12).
Stroke, Volume 55, Issue Suppl_1 , Page ATP212-ATP212, February 1, 2024. Background:Endovascular thrombectomy (EVT) for treatment of acute ischemic stroke (AIS) in the proximal cerebrovasculature has, since its inception, become part of the standard of care when addressing AIS. The study was approved by the local IRB.
Stroke, Volume 55, Issue Suppl_1 , Page ATP211-ATP211, February 1, 2024. Introduction:The extended Thrombolysis in Cerebral Infarction (eTICI) scale has been demonstrated to correlate strongly with clinical outcomes.
Stroke, Volume 55, Issue Suppl_1 , Page A85-A85, February 1, 2024. Intravenous thrombolysis was administered in 55 patients (22.1%) while general anesthesia was used in 94/248 patients (37.9%). years [SD 11.7], 208 [83.5%] male) were included. The median baseline NIHSS score was 23 (IQR 12-30) and median PC-ASPECTS was 9 (IQR 7-10).
Stroke, Volume 55, Issue Suppl_1 , Page ATP127-ATP127, February 1, 2024. Background/Purpose:Distal medium vessel occlusions (DMVOs) account for a large percentage of vessel occlusions resulting in acute ischemic stroke (AIS) with disabling symptoms. years old [mean+-SD], 35 female). for optimal sensitivity (71% [52.0-85.8%])
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionThrombolysis with recombinant tissue plasminogen activator remains vital to acute ischemic stroke (AIS) therapy. The admission National Institutes of Health Stroke Scale scores (NIHSS) were similar. A p‐value of <0.05
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content